Jrvinen A, Laine MK, Tikkanen R, et al
Despite semaglutide being a powerful weapon against obesity, The Endocrine Centers team promotes its use alongside healthy eating and regular physical activities
Semaglutide addresses calorie intake by curbing appetite
Tirzepatide and heart failure: In a phase III trial, tirzepatide has demonstrated significant benefits in obese patients with heart failure, reducing the risk of major complications, including urgent heart failure visits, hospitalisations, increased diuretic treatment, and cardiovascular-related deaths, by 38% compared to placebo
Start saving on Ozempic It only takes a few minutes to save on your Ozempic prescription
PlexusDx integrates genetic intelligence with compounded flexibilitya combination unavailable with fixed-dose brand-name productsto align treatment directly with your physiology